Apolipoprotein E ϵ4 and fatal cerebral amyloid angiopathy associated with dementia pugilistica
✍ Scribed by Barry D. Jordan; Andrew B. Kanik; Marchk S. Horwich; David Sweeney; Norman R. Relkin; Carol K. Petito; Sam Gandy
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 183 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
✦ Synopsis
electroencephalography (to demonstrate burst suppression), and we occasionally repeat computed tomographic scanning (to demonstrate cerebral edema or multiple cerebral infarcts) to assist in our assessment. Moreover, we often consider naloxone or flumazenil to reverse possible confounding drugs such as narcotics or benzodiazepines (e.g., midazolam). Only after we have marshaled the most pertinent clinical and laboratory data, do we address our prediction of outcome with family members.
Outcome in comatose survivors following cardiac arrest with myoclonus status is dismal 14, 51. This finding remains uncontroverted.
📜 SIMILAR VOLUMES
To better define the influence of apolipoprotein E (ApoE) epsilon 4 genotype on the cognitive and biochemical features of Alzheimer's disease (AD), cross-sectional analysis of global cognitive measures and cerebrospinal fluid studies gathered on AD subjects at a tertiary care facility between 1986 a